Cibc Private Wealth Group, LLC Tempest Therapeutics, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Tempest Therapeutics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 133 shares of TPST stock, worth $905. This represents 0.0% of its overall portfolio holdings.
Number of Shares
133
Previous 133
-0.0%
Holding current value
$905
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding TPST
# of Institutions
28Shares Held
2.04MCall Options Held
42.8KPut Options Held
72.9K-
Black Rock Inc. New York, NY550KShares$3.75 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA433KShares$2.95 Million0.0% of portfolio
-
Ubs Group Ag324KShares$2.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA298KShares$2.03 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA115KShares$780,1460.0% of portfolio
About Tempest Therapeutics, Inc.
- Ticker TPST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,418,900
- Market Cap $71M
- Description
- Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...